MDGL logo

Madrigal Pharmaceuticals (MDGL) Company Overview

Profile

Full Name:

Madrigal Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 6, 2007

Indexes:

Not included

Description:

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The corporation was registered in Delaware in September 2011. The headquarters is located in Pennsylvania. The company's main focus is on the drug MGL-3196 (resmetirom), which has the potential to be used for the treatment of a variety of liver conditions, including non-alcoholic steatohepatitis. Successful further development and final regulatory approval of resmetirom are crucial for the future success of Madrigal Pharmaceuticals, Inc.

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 25, 2016

Analyst ratings

Recent major analysts updates

Feb 27, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Citigroup
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Jan 10, 25 JMP Securities
Market Outperform
Nov 20, 24 Cantor Fitzgerald
Neutral
Nov 5, 24 B. Riley Securities
Neutral
Nov 1, 24 UBS
Buy
Oct 23, 24 Oppenheimer
Outperform
Oct 22, 24 HC Wainwright & Co.
Buy
Oct 11, 24 Cantor Fitzgerald
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Madrigal Pharmaceuticals?
  • Does Madrigal Pharmaceuticals pay dividends?
  • What sector is Madrigal Pharmaceuticals in?
  • What industry is Madrigal Pharmaceuticals in?
  • What country is Madrigal Pharmaceuticals based in?
  • When did Madrigal Pharmaceuticals go public?
  • Is Madrigal Pharmaceuticals in the S&P 500?
  • Is Madrigal Pharmaceuticals in the NASDAQ 100?
  • Is Madrigal Pharmaceuticals in the Dow Jones?
  • When was Madrigal Pharmaceuticals's last earnings report?
  • When does Madrigal Pharmaceuticals report earnings?
  • Should I buy Madrigal Pharmaceuticals stock now?

What is the ticker symbol for Madrigal Pharmaceuticals?

The ticker symbol for Madrigal Pharmaceuticals is NASDAQ:MDGL

Does Madrigal Pharmaceuticals pay dividends?

No, Madrigal Pharmaceuticals does not pay dividends

What sector is Madrigal Pharmaceuticals in?

Madrigal Pharmaceuticals is in the Healthcare sector

What industry is Madrigal Pharmaceuticals in?

Madrigal Pharmaceuticals is in the Biotechnology industry

What country is Madrigal Pharmaceuticals based in?

Madrigal Pharmaceuticals is headquartered in United States

When did Madrigal Pharmaceuticals go public?

Madrigal Pharmaceuticals's initial public offering (IPO) was on February 6, 2007

Is Madrigal Pharmaceuticals in the S&P 500?

No, Madrigal Pharmaceuticals is not included in the S&P 500 index

Is Madrigal Pharmaceuticals in the NASDAQ 100?

No, Madrigal Pharmaceuticals is not included in the NASDAQ 100 index

Is Madrigal Pharmaceuticals in the Dow Jones?

No, Madrigal Pharmaceuticals is not included in the Dow Jones index

When was Madrigal Pharmaceuticals's last earnings report?

Madrigal Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does Madrigal Pharmaceuticals report earnings?

The next expected earnings date for Madrigal Pharmaceuticals is May 7, 2025

Should I buy Madrigal Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions